Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer
Clinical trial NCT04068753 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04068753
- Sponsor
- University of Oklahoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-26
- Primary completion
- 2026-12-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.